Anthony J. Rothschild, MD, says that barriers to expensive antipsychotic drugs are shortsighted. He adds that the American Psychiatric Association, in accordance with some in Congress, recently rejected a CMS decision that would have restricted the number of antidepressants and antipsychotics Medicare beneficiaries could receive.
Anthony J. Rothschild, MD, says that barriers to expensive antipsychotic drugs are shortsighted. He adds that the American Psychiatric Association, in accordance with some in Congress, recently rejected a CMS decision that would have restricted the number of antidepressants and antipsychotics Medicare beneficiaries could receive.
Dr Rothschild is professor and Irving S. and Betty Brudnick Endowed Chair of Psychiatry, University of Massachusetts Medical School; director, UMass Medical Depression Center and Center for Psychopharmacologic Research and Treatment, and program director, Mood Disorders Comprehensive Consultation Clinic at UMass Memorial Medical Center.
“The bottom line is—whether it’s the state’s Medicaid or the federal government on Medicare—is that the amount of money you save on the price of the pill is small compared to the amount of money you might save by giving effective medications, because people are using less healthcare services, both mental and physical,” says Dr Rothschild.
ACA Network Regulatory Filings Are Inaccurate, Poorly Match Provider Directories
September 16th 2025A secret shopper survey (N = 8306) in Pennsylvania’s Affordable Care Act (ACA) Marketplace found inconsistencies between carrier regulatory filings and provider directories, frequent inaccuracies in regulatory filings, and challenges in securing timely appointments.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen